Zolgensma's long-term effects under the microscope in new 5-year study
NCT ID NCT05335876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 175 people with spinal muscular atrophy who previously received the gene therapy Zolgensma in clinical trials. Researchers will monitor them for 5 years to track serious side effects and developmental milestones. The goal is to understand how safe and effective the treatment remains over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
onasemnogene abeparvovec (Zolgensma)
What this could lead to
If successful, this study could confirm that a one-time dose of Zolgensma provides lasting benefits and is safe over many years for people with spinal muscular atrophy.
What could go wrong
This is a follow-up study, not a new treatment test. It may reveal unknown long-term side effects, and results depend on how well patients did in earlier trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY (SMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Child Hosp Of The Kings Daughters
RECRUITINGNorfolk, Virginia, 23507, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Novartis Investigative Site
RECRUITINGSydney, New South Wales, 2031, Australia
-
Novartis Investigative Site
RECRUITINGLeuven, 3000, Belgium
-
Novartis Investigative Site
RECRUITINGCuritiba, Paraná, 81520-060, Brazil
-
Novartis Investigative Site
RECRUITINGSão Paulo, São Paulo, 05403 000, Brazil
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Novartis Investigative Site
RECRUITINGChongqing, Chongqing Municipality, 400010, China
-
Novartis Investigative Site
RECRUITINGGuangzhou, Guangdong, 510623, China
-
Novartis Investigative Site
RECRUITINGChengdu, Sichuan, 610041, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100034, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100069, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100730, China
-
Novartis Investigative Site
RECRUITINGCopenhagen, 2100 O, Denmark
-
Novartis Investigative Site
RECRUITINGBron, 69677, France
-
Novartis Investigative Site
RECRUITINGGarches, 92380, France
-
Novartis Investigative Site
RECRUITINGStrasbourg, 67000, France
-
Novartis Investigative Site
RECRUITINGToulouse, 31059, France
-
Novartis Investigative Site
RECRUITINGRoma, RM, 00168, Italy
-
Novartis Investigative Site
RECRUITINGKurume, Fukuoka, 830-0011, Japan
-
Novartis Investigative Site
RECRUITINGShinjuku Ku, Tokyo, 1628666, Japan
-
Novartis Investigative Site
RECRUITINGKuala Lumpur, 50300, Malaysia
-
Novartis Investigative Site
RECRUITINGKuala Lumpur, 59100, Malaysia
-
Novartis Investigative Site
RECRUITINGUtrecht, 3584 CX, Netherlands
-
Novartis Investigative Site
RECRUITINGRiyadh, 11211, Saudi Arabia
-
Novartis Investigative Site
RECRUITINGSingapore, 119074, Singapore
-
Novartis Investigative Site
RECRUITINGBarcelona, 08035, Spain
-
Novartis Investigative Site
RECRUITINGKaohsiung City, 80756, Taiwan
-
Novartis Investigative Site
RECRUITINGTaipei, 10002, Taiwan
-
Novartis Investigative Site
RECRUITINGBangkok, 10700, Thailand
-
Novartis Investigative Site
RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Novartis Investigative Site
RECRUITINGNewcastle upon Tyne, NE1 4LP, United Kingdom
-
Novartis Investigative Site
RECRUITINGHanoi, 100000, Vietnam